1-20 of 74
Ping Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting T-Cell Lymphoma Using CD70-Directed Cord Blood-Derived CAR-NK Cells

Hind Rafei, Rafet Basar, Sunil Acharya, Patrick Zhang, Pinghua Liu, Sadie Mae Moseley, Ping Li, May Daher, MD, Nitin Agarwal, Mario L. Marques-Piubelli, Nadima Uprety, Luciana Melo Garcia, Mayra Shanley, Pinaki Banerjee, Ye Li, Samuel Levi Rosemore, Bijender Kumar, Ana K. Nunez Cortes, Alexander Biederstädt, Sanjida Islam, Mecit Kaplan, Bingqian Hu, Gohar Manzar, Paul Lin, David Marin, Richard E. Champlin, Francisco Vega, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4811.
https://doi.org/10.1182/blood-2023-184864
Published: 2023
Journal Articles

Characterization of Hemophagocytic Lymphohistio(HLH）in Relapsed Diffuse Large B-Cell Lymphoma Patients after CAR-T Therapy

Lili Zhou, Shiguang Ye, Xiuyong Dang, Shaoguang Li, Ping Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6276.
https://doi.org/10.1182/blood-2023-186563
Published: 2023
Journal Articles

Clinical Characteristics of Long-Term Survivors Treated with BCMA CAR T Cell

Fangce WANG, Bing Li, Ping Li, Shiguang Ye, Lili Zhou, Wenjun Zhang, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6865.
https://doi.org/10.1182/blood-2023-185161
Published: 2023
Journal Articles

BTK Inhibitors and Chidamide-Combined Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Lili Zhou, Shiguang Ye, Ping Li, Bing Li, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6258.
https://doi.org/10.1182/blood-2023-180524
Published: 2023
Journal Articles

Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy

Ping Li, Wei Liu, Shiguang Ye, Lili Zhou, Judy Zhu, Jiaqi Huang, Jing Li, Shigui Zhu, Chengxiao Zheng, Kevin Zhu, Xin Yao, Hui Wan, Yihong Yao, Aibin Liang, Dehui Zou
Journal: Blood
Blood (2023) 142 (Supplement 1): 2115.
https://doi.org/10.1182/blood-2023-181527
Published: 2023
Journal Articles

CLL Cell-Derived Exosomes Impair Immune Function and Normal Hematopoiesis in CLL

Ivo Veletic, David M. Harris, Uri Rozovski, Ping Li, Zhiming Liu, Taghi Manshouri, Maria Teresa S. Bertilaccio, George A. Calin, Rares-Constantin Drula, Koichi Takahashi, Ken Furudate, Muharrem Muftuoglu, Anwar Hossain, Alessandra Ferrajoli, Jan A. Burger, Nitin Jain, William G. Wierda, Srdan Verstovsek, Michael J. Keating, Zeev Estrov
Journal: Blood
Blood (2023) 142 (Supplement 1): 3264.
https://doi.org/10.1182/blood-2023-190712
Published: 2023
Journal Articles

Generation and Screening of Various CD70 CAR NK Cells Identify the Most Effective Construct Against Hematologic Malignancies

Sunil Acharya, Rafet Basar, May Daher, MD, Ping Li, Hind Rafei, Nadima Uprety, Emily Ensley, Mayra Shanley, Bijender Kumar, Pinaki Banerjee, Luciana Melo Garcia, Paul Lin, Vakul Mohanty, Yuchen Pan, Qi Miao, Kun Hee Kim, Xianli Jiang, Ye Li, Bin Liu, Ana K. Nunez Cortes, Patrick Zhang, Mohsen Fathi, Ali Rezvan, Melisa J Montalvo, Enli Liu, Navin Varadarajan, Ken Chen, David Marin, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4824.
https://doi.org/10.1182/blood-2023-189475
Published: 2023
Journal Articles

Neoplastic Monocyte-Derived Fibrocytes Induce Bone Marrow Fibrosis in Patients with Primary Myelofibrosis

Ivo Veletic, Taghi Manshouri, Christopher D. Pacheco, C. Cameron Yin, Ying Zhang, Ping Li, Evan N. Cohen, Javier A. Gomez, Jared K. Burks, Srdan Verstovsek, Zeev Estrov
Journal: Blood
Blood (2023) 142 (Supplement 1): 4516.
https://doi.org/10.1182/blood-2023-191024
Published: 2023
Journal Articles

To Investigate the Efficacy of Long-Term Step-Reduction Methylprednisolone in the Treatment of Severe Persistent Thrombocytopenia after CAR-T Cell Therapy

Haiyan Jiang, Ping Li, Lili Zhou, Shiguang Ye, Xiu Luo, Yan Lu, Bin Xue, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6934.
https://doi.org/10.1182/blood-2023-188386
Published: 2023
Journal Articles

CAR T-Cell Therapy Combined with PD-1 Inhibitors Significantly Improve the Efficacy and Prognosis of r/r DLBCL with TP53 Alterations

Bin Xue, Xiu Luo, Yifan Liu, Shiguang Ye, Lili Zhou, Shaoguang Li, Ping Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3515.
https://doi.org/10.1182/blood-2023-180500
Published: 2023
Journal Articles

Methotrexate in Combination with Orelabrutinib, Thiotepa, and Rituximab (R-MTO) Followed By Autologous Stem-Cell Transplant for Primary Central Nervous System Lymphoma Treatment

Lijie Xing, Haichen Wei, Dan Liu, Hui Wang, Ping Li, Linna Xie, Zengjun Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 6228.
https://doi.org/10.1182/blood-2023-186219
Published: 2023
Journal Articles

PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r ENKTL): Updates of the Phase Ib/II Scent Study

Gao Yan, Liling Zhang, Wenyu Li, Xu Wei, Ru Feng, Xue-Ping Li, Yu Chen, Huijing Wu, Xiaoxiao Wang, Bing Bai, Huiqiang Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1689.
https://doi.org/10.1182/blood-2023-186252
Published: 2023
Journal Articles

Development and Validation of a Clinical Prediction Model for the Efficacy of CD19 CAR T-Cell Therapy in DLBCL

Bin Xue, Xiu Luo, Yifan Liu, Lili Zhou, Shiguang Ye, Shaoguang Li, Ping Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2142.
https://doi.org/10.1182/blood-2023-184885
Published: 2023
Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Ping Li, Wen-Juan Yu, Lili Zhou, Min Yang, Shiguang Ye, Judy Zhu, Jiaqi Huang, Yan Zhang, Lanfang Li, Jing Zhao, Kevin Zhu, Jing Li, Chengxiao Zheng, Liping Lan, Hui Wan, Yihong Yao, Huilai Zhang, Daobin Zhou, Jie Jin, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1025.
https://doi.org/10.1182/blood-2023-182817
Published: 2023
Journal Articles

Novel Chemotherapy-Free Initial Treatment of Rituximab Biosimilar Plus Pegylated Interferon α-2b in Pts with Untreated Advanced Indolent B-Cell Non-Hodgkin's Lymphoma: Results of the Ripple 3-Year Follow-up Study

Gao Yan, Jianqiu Wu, Yunhong Huang, Hui Zhou, Ru Feng, Fei Li, Xue-Ping Li, Xiaoxiao Wang, Bing Bai, Yu-Hua Huang, Haixia He, Liqin Ping, Yanxia He, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4411.
https://doi.org/10.1182/blood-2023-186099
Published: 2023
Journal Articles

The Efficacy and Safety of Decitabine Combined with Fludarabine and Cyclophosphamide As Conditioning Regimen in Second CD19 CAR-T Infusion

Shiguang Ye, Lili Zhou, Yan Lu, Xiu Luo, Shaoguang Li, Ping Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6882.
https://doi.org/10.1182/blood-2023-184765
Published: 2023
Journal Articles

Zanubrutinib Combined Regimen As Bridging Treatment on Promising Clinical Outcome of CD19 Chimeric Antigen Receptor T-Cell Therapies in Relapsed or Refractory Large B-Cell Lymphoma

Yan Lu, Shiguang Ye, Lili Zhou, Ping Li, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6925.
https://doi.org/10.1182/blood-2023-182763
Published: 2023
Journal Articles

Radiotherapy Combined Chimeric Antigen Receptor T-Cells Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma（R/R DLBCL）

Lili Zhou, Yifan Liu, Shiguang Ye, Ping Li, Shaoguang Li, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3137.
https://doi.org/10.1182/blood-2023-184352
Published: 2023
Journal Articles

Combination Anti-PD1 Antibody and Rituximab Followed By R-CHOP for Elderly Patients with Newly Diagnosed DLBCL: Analysis of the Phase II TREND Trial

Gao Yan, Xiaoxiao Wang, Bing Bai, Xue-Ping Li, Suxia Lin, Yanxia He, Liqin Ping, Cheng Huang, Jibin Li, Jiaying Mao, Huiqiang Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 3737–3738.
https://doi.org/10.1182/blood-2022-166936
Published: 2022
Journal Articles

DNA-Demethylating Agents Combined with Anti-PD-1 Inhibitors Showed Activity in Patients with Relapsed or Refractory Extranodal NK/T Cell Lymphoma Who Have Failed Immunotherapy: An Exploratory Study

Gao Yan, Cheng Huang, Xue-Ping Li, Xiaoxiao Wang, Bing Bai, Yanxia He, Liqin Ping, Huiqiang Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 9393–9394.
https://doi.org/10.1182/blood-2022-165874
Published: 2022